<DOC>
	<DOCNO>NCT00747214</DOCNO>
	<brief_summary>This study Multicenter , Randomized , Blinded Study Comparing Effect CRx-102 Plus DMARD Therapy Placebo Plus DMARD Therapy Serum C Reactive Protein ( CRP ) Cytokines Subjects Rheumatoid Arthritis . This Phase II , 6-week blind study plan 60 subject moderate severe rheumatoid arthritis ( RA ) .</brief_summary>
	<brief_title>A Study Comparing CRx-102 Plus Disease-modifying Anti-rheumatic Drug ( DMARD ) Therapy Placebo Plus DMARD Therapy RA</brief_title>
	<detailed_description>The primary objective study : • Compare response CRx-102 plus DMARD therapy placebo plus DMARD therapy lower CRP level rheumatoid arthritis subject . The secondary objective study : - Evaluate change inflammatory cytokine subject treat CRx-102 plus DMARD therapy placebo plus DMARD therapy . - Evaluate efficacy CRx-102 plus DMARD therapy placebo plus DMARD therapy use ACR-20 DAS28 index well fatigue scale .</detailed_description>
	<mesh_term>Arthritis</mesh_term>
	<mesh_term>Arthritis , Rheumatoid</mesh_term>
	<mesh_term>Antirheumatic Agents</mesh_term>
	<criteria>Was 18 year age old Had moderate severe RA Had least 3 swollen joint ( maximum 28 ) 3 tender joint ( maximum 28 ) Had Baseline CRP level least 2.2 mg/L DAS28 score &gt; 4.5 Had DMARD therapy least 3 month stable dose DMARD therapy least 28 day prior enrollment Had negative pregnancy test ( female ) Was take glucocorticoid screen Female subject pregnant lactating child bear potential use acceptable method birth control ( barrier abstinence ) . Female subject use hormonal birth control enrol . Subject currently take steroid ( glucocorticoid ) . All glucocorticoid must discontinue least one month prior enter study . Intraarticular , intramuscular , intravenous glucocorticoid must give least 6 week prior enter study . Subject currently take 81 mg aspirin daily . Subject currently take statin , unless she/he stable dose statin least 3 month prior enter trial . Subject active infection recent surgical procedure within 30 day study initiation . Subject uncontrolled diabetes mellitus define HbA1C value ≥ 7.0 % . Subject knowingly HIV Hepatitis . Subject undergone administration investigational drug within 30 day study initiation . Subject history hypersensitivity steroid and/or dipyridamole . Subject limited mental capacity language skills simple instruction follow information regard adverse event provide .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2014</verification_date>
	<keyword>Rheumatoid Arthritis</keyword>
	<keyword>RA</keyword>
	<keyword>DMARD</keyword>
	<keyword>CRP</keyword>
</DOC>